Randomized phase II trial of presurgical androgen deprivation therapy (ADT) with or without axitinib in prostate cancer (PCa) presenting with lymph node (LN) metastasis.

被引：0
|
作者：
Zurita, Amado J.
Tidwell, Rebecca Slack
Troncoso, Patricia
Chapin, Brian Francis
Harris, Deborah
Pisters, Louis L.
Araujo, John C.
Pettaway, Curtis Alvin
Aparicio, Ana
Tu, Shi-Ming
Papadopoulos, John N.
Wang, Jennifer
Logothetis, Christopher
Pagliaro, Lance C.
Davis, John W.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Div Canc Med, Houston, TX 77030 USA
[3] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.5078
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5078
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Presurgical axitinib and androgen deprivation therapy (ADT) in prostate cancer (PCa) patients (pts) presenting with lymph node (LN) metastasis
    Zurita, Arnado J.
    Pagliaro, Lance C.
    Troncoso, Patricia
    Davis, John W.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Presurgical docetaxel (Doc) and androgen deprivation therapy (ADT) in lymph node-positive prostate cancer (PCa).
    Pagliaro, L. C.
    Zurita, A. J.
    Araujo, J. C.
    Ward, J. F.
    Davis, J. W.
    Pettaway, C. A.
    Tu, S.
    Kim, J.
    Dieringer, P.
    Logothetis, C.
    Pisters, L. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Survival analysis of the randomized phase II trial to investigate androgen signaling inhibitors with or without androgen deprivation therapy (ADT) for castration-sensitive prostate cancer: LACOG 0415.
    Maluf, Fernando Cotait
    Soares, Andrey
    Bastos, Diogo Assed
    Schutz, Fabio A. B.
    Cronemberger, Eduardo
    Luz, Murilo
    Martins, Suelen P. S.
    Muniz, David Queiroz Borges
    Carcano, Flavio Mavignier
    Smaletz, Oren
    Peixoto, Abio A.
    Gomes, Andrea J.
    Cruz, Felipe Melo
    Franke, Fabio
    Herchenhorn, Daniel
    Gidekel, Rosemarie
    Rebelatto, Taiane Francieli
    Gomes, Rafaela
    Souza, Vinicius Carrera
    Fay, Andre P.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] A phase II trial of androgen deprivation therapy (ADT) plus chemotherapy as initial treatment for local failures or advanced prostate cancer
    Robert Amato
    Mika Stepankiw
    Patricia Gonzales
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1629 - 1634
  • [5] A phase II trial of androgen deprivation therapy (ADT) plus chemotherapy as initial treatment for local failures or advanced prostate cancer
    Amato, Robert
    Stepankiw, Mika
    Gonzales, Patricia
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (06) : 1629 - 1634
  • [6] Outcome of adjuvant versus salvage androgen deprivation therapy (ADT) following radical prostatectomy with/without pelvic lymph node dissection for prostate cancer patients with adverse pathologic feature(s) or with positive regional lymph node metastasis
    Boonyapanichskul, Pavich
    Woranisarakul, Varat
    Leewansangtong, Sunai
    Srinualnad, Sittiporn
    Nualyong, Chaiyong
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 : 9 - 9
  • [7] A randomized phase II study of apalutamide (APA), androgen deprivation therapy (ADT), or APA plus ADT in patients (pts) with biochemically relapsed (BCR) prostate cancer (PC)
    Aggarwal, Rahul Raj
    Alumkal, Joshi J.
    Szmulewitz, Russell Zelig
    Higano, Celestia S.
    Bryce, Alan Haruo
    Lopez-Gitlitz, Angela
    McCarthy, Sharon Anne
    Miladinovic, Branko
    McQuarrie, Kelly
    Thomas, Shibu
    Small, Eric Jay
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [8] Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer: A Phase II Randomized Controlled Trial
    Dai, Bo
    Zhang, Sheng
    Wan, Fang-Ning
    Wang, Hong-Kai
    Zhang, Jun -Yu
    Wang, Qi-Feng
    Kong, Yun-Yi
    Ma, Xue-Jun
    Mo, Miao
    Zhu, Yao
    Qin, Xiao-Jian
    Lin, Guo-Wen
    Ye, Ding -Wei
    EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (05): : 519 - 525
  • [9] A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy
    Shabbir M. H. Alibhai
    Daniel Santa Mina
    Paul Ritvo
    George Tomlinson
    Catherine Sabiston
    Murray Krahn
    Sara Durbano
    Andrew Matthew
    Padraig Warde
    Meagan O’Neill
    Narhari Timilshina
    Roanne Segal
    Nicole Culos-Reed
    BMC Cancer, 19
  • [10] A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local Therapy
    McKay, Rana R.
    Zurita, Amado J.
    Werner, Lillian
    Bruce, Justine Y.
    Carducci, Michael A.
    Stein, Mark N.
    Heath, Elisabeth I.
    Hussain, Arif
    Tran, Hai T.
    Sweeney, Christopher J.
    Ross, Robert W.
    Kantoff, Philip W.
    Slovin, Susan F.
    Taplin, Mary-Ellen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (16) : 1913 - +
12345